- Home
- OUST vs BBNX Comparison
OUST vs BBNX Comparison
Compare OUST & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OUST
- BBNX
- Stock Information
- Founded
- OUST 2015
- BBNX 2015
- Country
- OUST United States
- BBNX United States
- Employees
- OUST N/A
- BBNX N/A
- Industry
- OUST Industrial Machinery/Components
- BBNX Medical/Dental Instruments
- Sector
- OUST Technology
- BBNX Health Care
- Exchange
- OUST Nasdaq
- BBNX Nasdaq
- Market Cap
- OUST 1.1B
- BBNX 967.6M
- IPO Year
- OUST N/A
- BBNX 2025
- Fundamental
- Price
- OUST $29.86
- BBNX $22.26
- Analyst Decision
- OUST Strong Buy
- BBNX Strong Buy
- Analyst Count
- OUST 6
- BBNX 10
- Target Price
- OUST $23.83
- BBNX $26.10
- AVG Volume (30 Days)
- OUST 3.0M
- BBNX 1.2M
- Earning Date
- OUST 11-06-2025
- BBNX 11-06-2025
- Dividend Yield
- OUST N/A
- BBNX N/A
- EPS Growth
- OUST N/A
- BBNX N/A
- EPS
- OUST N/A
- BBNX N/A
- Revenue
- OUST $125,848,000.00
- BBNX $78,022,000.00
- Revenue This Year
- OUST $33.30
- BBNX $42.80
- Revenue Next Year
- OUST $36.50
- BBNX $34.58
- P/E Ratio
- OUST N/A
- BBNX N/A
- Revenue Growth
- OUST 26.37
- BBNX 550.45
- 52 Week Low
- OUST $6.06
- BBNX $8.89
- 52 Week High
- OUST $36.25
- BBNX $26.66
- Technical
- Relative Strength Index (RSI)
- OUST 51.77
- BBNX 56.75
- Support Level
- OUST $26.29
- BBNX $19.07
- Resistance Level
- OUST $28.95
- BBNX $21.08
- Average True Range (ATR)
- OUST 2.42
- BBNX 1.44
- MACD
- OUST -0.38
- BBNX -0.45
- Stochastic Oscillator
- OUST 37.54
- BBNX 52.15
About OUST Ouster Inc.
Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and Pacific, Europe, Middle East, and Africa regions. It derives maximum revenue from Americas.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.